Literature DB >> 25402574

Biomarkers for understanding Ebola virus disease.

Anita K McElroy1, Christina F Spiropoulou.   

Abstract

Entities:  

Keywords:  EVD; biomarkers; cytokines; ebola

Mesh：

Substances：

Year:  2014        PMID： 25402574      PMCID： PMC4605416          DOI： 10.2217/bmm.14.75

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  17 in total

1.  An outbreak of Ebola in Uganda.

Authors:  S I Okware; F G Omaswa; S Zaramba; A Opio; J J Lutwama; J Kamugisha; E B Rwaguma; P Kagwa; M Lamunu
Journal:  Trop Med Int Health       Date:  2002-12       Impact factor: 2.622

2.  Emergence of Zaire Ebola virus disease in Guinea.

Authors:  Sylvain Baize; Delphine Pannetier; Lisa Oestereich; Toni Rieger; Lamine Koivogui; N'Faly Magassouba; Barrè Soropogui; Mamadou Saliou Sow; Sakoba Keïta; Hilde De Clerck; Amanda Tiffany; Gemma Dominguez; Mathieu Loua; Alexis Traoré; Moussa Kolié; Emmanuel Roland Malano; Emmanuel Heleze; Anne Bocquin; Stephane Mély; Hervé Raoul; Valérie Caro; Dániel Cadar; Martin Gabriel; Meike Pahlmann; Dennis Tappe; Jonas Schmidt-Chanasit; Benido Impouma; Abdoul Karim Diallo; Pierre Formenty; Michel Van Herp; Stephan Günther
Journal:  N Engl J Med       Date:  2014-04-16       Impact factor: 91.245

3.  Early immune responses accompanying human asymptomatic Ebola infections.

Authors:  E M Leroy; S Baize; P Debre; J Lansoud-Soukate; E Mavoungou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

4.  Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Authors:  Siddhartha Mahanty; Karen Hutchinson; Sudhanshu Agarwal; Michael McRae; Pierre E Rollin; Bali Pulendran
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

5.  Inflammatory responses in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; A J Georges; M-C Georges-Courbot; M Capron; I Bedjabaga; J Lansoud-Soukate; E Mavoungou
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 6.  Post-exposure therapy of filovirus infections.

Authors:  Gary Wong; Xiangguo Qiu; Gene G Olinger; Gary P Kobinger
Journal:  Trends Microbiol       Date:  2014-04-30       Impact factor: 17.079

7.  Human asymptomatic Ebola infection and strong inflammatory response.

Authors:  E M Leroy; S Baize; V E Volchkov; S P Fisher-Hoch; M C Georges-Courbot; J Lansoud-Soukate; M Capron; P Debré; J B McCormick; A J Georges
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

8.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

9.  Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.

Authors:  F Villinger; P E Rollin; S S Brar; N F Chikkala; J Winter; J B Sundstrom; S R Zaki; R Swanepoel; A A Ansari; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

Review 10.  Ebola virus vaccines: an overview of current approaches.

Authors:  Andrea Marzi; Heinz Feldmann
Journal:  Expert Rev Vaccines       Date:  2014-02-27       Impact factor: 5.217
View more
  4 in total

1.  Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

Authors:  Anita K McElroy; Jessica R Harmon; Timothy D Flietstra; Shelley Campbell; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Christopher J Kratochvil; Peter C Iwen; Philip W Smith; Rafi Ahmed; Stuart T Nichol; Christina F Spiropoulou
Journal:  Clin Infect Dis       Date:  2016-06-27       Impact factor: 9.079

2.  Analysis of Ebola virus polymerase domains to find strain-specific differences and to gain insight on their pathogenicity.

Authors:  Seema Patel; Snigdha Patel
Journal:  Virusdisease       Date:  2016-07-30

3.  Development of a Well-Characterized Rhesus Macaque Model of Ebola Virus Disease for Support of Product Development.

Authors:  Kendra J Alfson; Yenny Goez-Gazi; Michal Gazi; Hilary Staples; Marc Mattix; Anysha Ticer; Benjamin Klaffke; Kaylee Stanfield; Priscilla Escareno; Patrick Keiser; Anthony Griffiths; Ying-Liang Chou; Nancy Niemuth; Gabe T Meister; Chris M Cirimotich; Ricardo Carrion
Journal:  Microorganisms       Date:  2021-02-26

4.  Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.

Authors:  Ronald B Reisler; Chenggang Yu; Michael J Donofrio; Travis K Warren; Jay B Wells; Kelly S Stuthman; Nicole L Garza; Sean A Vantongeren; Ginger C Donnelly; Christopher D Kane; Mark G Kortepeter; Sina Bavari; Anthony P Cardile
Journal:  Emerg Infect Dis       Date:  2017-08       Impact factor: 6.883
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.